E

EXO Biologics (Public limited company)

EXO BIOLOGICS
BE 0732.982.379 Active ●Boulevard de Patience et Beaujonc 3, 4000 Liège

EXO Biologics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0732.982.379. It was founded on 29-08-2019. Its registered office is in Liège. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 2 927 249 and a loss of € 2 321 972. These accounts report 5.6 full-time equivalents. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 16-10-2026.

Company information

Status
Active
Enterprise number
BE 0732.982.379
VAT registered
Yes
Founded
29-08-2019
Latest accounts
2025
Employees
5.6 FTE
Region
Wallonia
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Boulevard de Patience et Beaujonc 3, 4000 Liège
Main activity
Scientific research and development
NACE activities
72109 Recherche-développement en autres sciences physiques et naturelles
21209 Fabrication d'autres produits pharmaceutiques
72101 Recherche-développement en biotechnologie

Key figures of EXO Biologics

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -2 321 972-13 %€ -2 061 102+60 %€ -5 132 868-1 207 %€ -392 575
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 2 927 249-10 %€ 3 253 188-32 %€ 4 811 846€ -3 240 347
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 11 698 962-7 %€ 12 552 709+39 %€ 9 036 798+189 %€ 3 122 115
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 409 407-85 %€ 2 769 573€ -225 313€ 541 066
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
5.6-63 %15-10 %16.6-

Financial estimate

Financial health grade B, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
8 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Liège.

CompanyTown
Advanced Coatings & Construction Solutions 4000 Liège
Inokura 4000 Liège
ERAL TRADING 4000 Liège
SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE 4000 Liège
MEDIXBEL 4000 Liège
GABRIEL DELEU 4000 Liège
TER-Consult 4000 Liège
BIO-SOURCING 4000 Liège
Looking for more information about EXO Biologics?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is EXO Biologics still active? Yes. The Crossroads Bank for Enterprises lists EXO Biologics as active.

What is the VAT number of EXO Biologics? The VAT number of EXO Biologics is BE 0732.982.379.

When was EXO Biologics founded? EXO Biologics was founded on 29-08-2019.

What is the address of EXO Biologics? The current registered office of EXO Biologics is Boulevard de Patience et Beaujonc 3, 4000 Liège.

When did EXO Biologics last file annual accounts? The latest annual accounts of EXO Biologics were filed on 16-07-2026.

Does EXO Biologics file its annual accounts on time? Yes. EXO Biologics filed its annual accounts within the legal deadline for each of its last 4 financial years.

How many employees does EXO Biologics have? EXO Biologics employs 5.6 full-time equivalents according to its most recent annual accounts.

Is EXO Biologics financially healthy? Addrly gives EXO Biologics a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is EXO Biologics profitable? The annual accounts of EXO Biologics for 2025 show a loss of € 2 321 972.

What is the equity of EXO Biologics? The equity of EXO Biologics was € 2 927 249 at the close of the 2025 financial year.

Who are the directors of EXO Biologics? The annual accounts of EXO Biologics record 8 mandates. The names, roles and dates are visible with a free account.

Can EXO Biologics receive Peppol e-invoices? Yes. EXO Biologics is registered on the Peppol network and can receive structured electronic invoices.

What does EXO Biologics do? The main activity of EXO Biologics is: Scientific research and development.

Sources

How Addrly builds and refreshes this data